Beijing Science Sun Pharmaceutical Co Ltd (300485.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE100002110
Beijing Science Sun Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 416.48 m CNY | 404.72 m CNY |
| Gross profit | 273.26 m CNY | 263.53 m CNY |
| Operating income | -82.97 m CNY | -8.87 m CNY |
| EBIT | -83.55 m CNY | 12.76 m CNY |
| Net income | -68.85 m CNY | 14.57 m CNY |
| Diluted EPS – continuing operations | -0.14 CNY | 0.03 CNY |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Beijing Science Sun Pharmaceutical Co Ltd
Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. The company offers products for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, and other drugs. It is also involved in raw materials, solid oral preparations, and health products; extraction of traditional Chinese medicine; manufacture of Chinese and Western medicine preparations; research, development, production, and sales of tablets, hard capsules, powders, granules, and active pharmaceutical ingredients; outward investment, technology introduction and exchange, international business development, livestock and poultry production, and research and development of bio-organic fertilizers and bio-feeds. In addition, the company is engaged venture capital; equity investment through private equity funds; technology development, transfer, and services for biological products, pharmaceuticals, diagnostic reagents, and medical devices; biotechnology information consulting; sales of immunoassay reagents and laboratory instruments; research, development and industrialization of human vaccines; investment management and consulting for non-securities businesses, as well as inspection and testing services, consulting services, and health food production. The company was founded in 1999 and is headquartered in Beijing, China.
More stocks
- Ability Opto-Electronics Technology Co Ltd (3362.TWO)
- Hainan Haiqi Transportation Group Co Ltd (603069.SS)
- Ovid Therapeutics Inc. (OVID)
- MHP SE (MHPC.L)
- Visco Vision Inc. (6782.TW)
- Yupi Indo Jelly Gum PT Tbk (YUPI.JK)
- Invengo Information Technology Co Ltd (002161.SZ)
- Puyang Refractories Group Co Ltd (002225.SZ)
- Boryung Pharm (003850.KS)
- Zhejiang MustangBattery Co.Ltd (605378.SS)
- Weikeng Industrial Co Ltd (3033.TW)
- Marimaca Copper Corp (MARI.TO)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.